A MULTICENTER, SINGLE-ARM, OPEN-LABEL SAFETY AND QUALITY OF LIFE STUDY OF LENALIDOMIDE PLUS DEXAMETHASONE IN PREVIOUSLY TREATED PATIENTS WITH MULTIPLE MYELOMA

  • Michael O'Dwyer

Research output: Other contribution (Published)Other contribution

Original languageEnglish (Ireland)
Media of outputMeeting
Volume95
Publication statusPublished - 1 Jun 2010

Cite this